[go: up one dir, main page]

AP2014007699A0 - Compositions and methods for treating hepatitis C virus - Google Patents

Compositions and methods for treating hepatitis C virus

Info

Publication number
AP2014007699A0
AP2014007699A0 AP2014007699A AP2014007699A AP2014007699A0 AP 2014007699 A0 AP2014007699 A0 AP 2014007699A0 AP 2014007699 A AP2014007699 A AP 2014007699A AP 2014007699 A AP2014007699 A AP 2014007699A AP 2014007699 A0 AP2014007699 A0 AP 2014007699A0
Authority
AP
ARIPO
Prior art keywords
virus
compositions
methods
treating hepatitis
hepatitis
Prior art date
Application number
AP2014007699A
Inventor
Darryl G Cleary
Adrian S Ray
Dimitrios Stefanidis
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/055621 external-priority patent/WO2013040492A2/en
Priority claimed from US13/661,509 external-priority patent/US20130109647A1/en
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Priority claimed from PCT/US2012/066605 external-priority patent/WO2013082003A1/en
Publication of AP2014007699A0 publication Critical patent/AP2014007699A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2014007699A 2011-11-29 2012-11-27 Compositions and methods for treating hepatitis C virus AP2014007699A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161564500P 2011-11-29 2011-11-29
PCT/US2012/055621 WO2013040492A2 (en) 2011-09-16 2012-09-14 Methods for treating hcv
US201261707459P 2012-09-28 2012-09-28
US13/661,509 US20130109647A1 (en) 2011-10-31 2012-10-26 Methods and compositions for treating hepatitis c virus
PCT/US2012/066605 WO2013082003A1 (en) 2011-11-29 2012-11-27 Compositions and methods for treating hepatitis c virus

Publications (1)

Publication Number Publication Date
AP2014007699A0 true AP2014007699A0 (en) 2014-06-30

Family

ID=48803225

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2014007699A AP2014007699A0 (en) 2011-11-29 2012-11-27 Compositions and methods for treating hepatitis C virus

Country Status (4)

Country Link
AP (1) AP2014007699A0 (en)
EC (1) ECSP21087299A (en)
IL (1) IL232889A (en)
MY (1) MY187735A (en)

Also Published As

Publication number Publication date
IL232889A (en) 2016-07-31
IL232889A0 (en) 2014-07-31
ECSP21087299A (en) 2022-02-25
MY187735A (en) 2021-10-15

Similar Documents

Publication Publication Date Title
SG11201402609RA (en) Compositions and methods for treating hepatitis c virus
ZA201307914B (en) Compositions and methods for inhibiting gene expression of hepatitis b virus
IL221033A0 (en) Hepatitis c virus inhibitors
EP2575819A4 (en) Hepatitis c virus inhibitors
IL231515A (en) Compositions for treating hcv
ZA201306720B (en) Hepatitis c virus inhibitors
EP2757887A4 (en) Pyrrolopyridinone compounds and methods for treating hiv
IL229270B (en) Hepatitis c virus inhibitors
IL224298A (en) Hepatitis c virus inhibitors
EP2768517A4 (en) Hepatitis c virus inhibitors
ZA201404494B (en) Method for treating hepatitis c virus infection using quercetin-containing compositions
EP2603080A4 (en) Hepatitis c virus inhibitors
ZA201501752B (en) Methods for treating hepatitis c
ZA201309356B (en) Hepatitis c virus inhibitors
ZA201205547B (en) Therapies for treating hepatitis c virus infection
ZA201503458B (en) Hepatitis c virus inhibitors
EP2869821A4 (en) Compositions and methods for treating and inhibiting viral infections
ZA201501758B (en) Methods for treating hepatitis c
ZA201207226B (en) Compositions and methods for treating viral diseases
SG11201402899TA (en) Methods and compositions for treating viral diseases
PL2838903T3 (en) Methods and compositions for treating viral infections
LT2850075T (en) Piperazine-piperidine compounds as hepatitis c virus inhibitors
IL232889A0 (en) Compositions and methods for treating hepatitis c virus
EP2826486A4 (en) Agent for the treatment of hepatitis c virus
EP2747765A4 (en) Compositions and methods for treating viral diseases